Highlights from Advanced Therapies Europe 2025

This week, the VIVEbiotech team attended Advanced Therapies Europe, organised by Phacilitate at the Hotel Arts Barcelona. It was an excellent opportunity to strengthen collaborations with current partners, establish new connections and explore emerging technologies that are shaping the future of advanced therapies.

During the event, VIVEbiotech’s President Patricio Massera interviewed Chief Business Development Officer Natalia Elizalde who highlighted two key points:

• The growing relevance of in-vivo lentiviral vector projects in advanced therapies.

• How VIVEbiotech is preparing for the future by expanding its capabilities to better support partners.

You can watch the full video here.